Part 1. The Postpartum Metabolic Puzzle
The birth of a child produces one of the most abrupt physiological transitions in normal human life. During pregnancy, a woman’s metabolism, hormones, immune system, nutritional requirements, and sleep patterns are altered to support both mother and developing child. At delivery, many of these adaptations change rapidly. Within days, the mother must recover from childbirth while often beginning lactation and adapting to interrupted sleep and the demands of caring for a newborn. It is also during this period that some women experience significant disturbances of mood and, much more rarely, severe psychiatric illness.
Postpartum psychiatric illness occurs along a spectrum. Transient emotional disturbance, commonly called the “baby blues,” is frequent. Postpartum depression is considerably more serious, while postpartum psychosis is rare but potentially life-threatening. Postpartum psychosis occurs in approximately one to two women per thousand deliveries and commonly begins within the first weeks following childbirth. Modern research has implicated hormonal changes, immune activity, genetic susceptibility, and disruption of sleep and circadian rhythms, but no single mechanism adequately explains why childbirth acts as such a powerful psychiatric trigger in susceptible women.
One potentially important part of this transition involves tryptophan and vitamin B3 (niacin) metabolism. Tryptophan is an essential amino acid: the human body cannot manufacture it and therefore ultimately depends upon dietary sources. Tryptophan is required for protein synthesis, but it also serves as the starting material for several biologically important pathways. A small proportion can be used in the production of serotonin and melatonin, while a much larger proportion normally enters the kynurenine pathway. This pathway produces several neurologically active compounds and ultimately contributes to the synthesis of nicotinamide adenine dinucleotide, or NAD+, a molecule essential to cellular energy metabolism and numerous other cellular processes.
Pregnancy produces a striking alteration in this system. Research examining hundreds of pregnant women found that urinary metabolites of the tryptophan-niacin pathway increased progressively beginning in mid-pregnancy and reached approximately two to three times nonpregnant levels during late pregnancy. After childbirth, these metabolites declined toward nonpregnant levels. Earlier research likewise found that conversion of tryptophan into niacin metabolites was considerably more efficient during pregnancy than during the postpartum state.
This raises an intriguing question. What happens in a woman whose supply of tryptophan, niacin, or other nutrients involved in these pathways is marginal when the enhanced metabolic state of pregnancy suddenly ends?
The question becomes more significant because postpartum research has independently identified abnormalities involving tryptophan. A systematic review and meta-analysis found that lower total blood tryptophan during the first five days following childbirth was significantly associated with postpartum depression. This does not demonstrate that insufficient dietary tryptophan causes postpartum depression, nor does it establish that tryptophan supplementation would prevent it. It does, however, indicate that tryptophan metabolism is a legitimate biological variable in postpartum mood disorders and deserves further investigation.
These observations invite reconsideration of an older and controversial psychiatric theory. Beginning in the 1950s, Canadian psychiatrist Dr. Abram Hoffer, working closely with Humphry Osmond, proposed that disturbances involving vitamin B3, adrenaline metabolism, oxidative chemistry, and individual biochemical requirements could contribute to schizophrenia and certain psychotic illnesses. Hoffer became particularly associated with the therapeutic use of large doses of niacin or niacinamide. His theories, especially the proposed role of adrenochrome, remained controversial and were never accepted as an established explanation for schizophrenia.
The purpose of this paper is not to assume that Hoffer was correct, nor to propose that postpartum depression is simply a vitamin B3 deficiency. Rather, it asks a narrower question: whether modern knowledge of pregnancy and postpartum metabolism provides sufficient reason to reconsider portions of Hoffer’s biochemical reasoning in this particular physiological setting.
Such an investigation must consider several processes together. Pregnancy substantially increases tryptophan-to-niacin metabolism. That adaptation diminishes following delivery. At the same time, the mother encounters major hormonal changes, physical recovery, possible nutritional depletion, lactation, interrupted sleep, and psychological and physiological stress. Stress itself can influence tryptophan metabolism through the kynurenine pathway, providing another possible connection between the postpartum environment and metabolic vulnerability.
Breastfeeding introduces another participant into this metabolic system: the infant. Mother and child are no longer physiologically joined by the placenta, but they remain nutritionally connected through breast milk. Maternal nutritional status may therefore affect not only the mother but potentially the nutrient supply available to the infant. If maternal nutritional insufficiency contributed to infant irritability or poor sleep—a possibility that would require independent evidence—the resulting increase in crying and maternal sleep disruption could conceivably intensify the mother's stress. This suggests the possibility of a mother-infant feedback loop, although several links in that proposed chain remain hypothetical.
The central hypothesis examined in this paper can therefore be stated cautiously: in a susceptible woman, the abrupt postpartum alteration of tryptophan-niacin metabolism, combined with nutritional demands, lactation, stress, and sleep disruption, might contribute to a biochemical environment favorable to postpartum mood disturbance or psychosis.
Hoffer's work provides one historical framework through which to examine this possibility. Modern research on tryptophan, kynurenine, niacin and NAD+ provides another. Bringing the two together does not establish a treatment. It does, however, produce a series of specific and testable questions about maternal nutrition and postpartum mental health.
The first task is therefore to understand what Hoffer actually proposed, why he believed vitamin B3 could influence serious psychiatric illness, what clinical evidence he offered, and why his conclusions became so controversial.
Part 2. Hoffer and Osmond: Niacin, Adrenaline, and the Adrenochrome Hypothesis
